Background Image
Table of Contents Table of Contents
Previous Page  29 / 68 Next Page
Information
Show Menu
Previous Page 29 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 6, November/December 2015

AFRICA

227

An open-access mobile compatible electronic patient

register for rheumatic heart disease (‘eRegister’) based

on the World Heart Federation’s framework for patient

registers

Joris van Dam, John Musuku, Liesl J Zühlke, Mark E Engel, Nick Nestle, Brigitta Tadmor,

Jonathan Spector, Bongani M Mayosi

Abstract

Background:

Rheumatic heart disease (RHD) remains a major

disease burden in low-resource settings globally. Patient regis-

ters have long been recognised to be an essential instrument

in RHD control and elimination programmes, yet to date rely

heavily on paper-based data collection and non-networked

data-management systems, which limit their functionality.

Objectives:

To assess the feasibility and potential benefits of

producing an electronic RHD patient register.

Methods:

We developed an eRegister based on the World

Heart Federation’s framework for RHD patient registers

using CommCare, an open-source, cloud-based software for

health programmes that supports the development of custom-

ised data capture using mobile devices.

Results:

The resulting eRegistry application allows for simul-

taneous data collection and entry by field workers using

mobile devices, and by providers using computer terminals

in clinics and hospitals. Data are extracted from CommCare

and are securely uploaded into a cloud-based database that

matches the criteria established by the WHF framework. The

application can easily be tailored to local needs by modify-

ing existing variables or adding new ones. Compared with

traditional paper-based data-collection systems, the eRegister

reduces the risk of data error, synchronises in real-time,

improves clinical operations and supports management of

field team operations.

Conclusions:

The user-friendly eRegister is a low-cost, mobile,

compatible platform for RHD treatment and prevention

programmes based on materials sanctioned by the World

Heart Federation. Readily adaptable to local needs, this

paperless RHD patient register program presents many prac-

tical benefits.

Keywords:

rheumatic heart disease, registries, mobile health,

open-source model

Submitted 21/11/14, accepted 10/6/15

Published online 6/10/15

Cardiovasc J Afr

2015;

26

: 227–233

www.cvja.co.za

DOI: 10.5830/CVJA-2015-058

Rheumatic heart disease (RHD) was largely eliminated from

most high-income countries decades ago but it remains a

major cause of cardiovascular disease in sub-Saharan Africa,

indigenous Australia, south-central Asia, the Pacific region,

and other low-resource settings globally.

1,2

At least 15 to 20

million people are affected and more than 280 000 new cases

are diagnosed each year,

3

although recent data from population-

based screening using echocardiography suggest that the true

prevalence could be up to tenfold higher.

4–6

The World Heart Federation (WHF), an association of

worldwide heart foundations and medical societies, is the leading

international non-governmental organisation concerned with

cardiovascular disease prevention.

7

A key strategic target put

forth by WHF is the use of comprehensive register-based

control programmes in regions where RHD is endemic.

7

Patient

registers are instrumental in helping to organise the medical

care of patients with RHD, minimising the loss to follow up,

and maximising the likelihood of compliance with therapeutic

regimens.

7-11

This is particularly important in patients with RHD,

many of whom require regular antibiotic therapy for decades in

order to mitigate the progression of heart disease.

Registers also facilitate monitoring of longitudinal patient

outcomes, and can be used to compile epidemiological data

for use in programme planning and advocacy activities.

7,11,12

Furthermore, patient registers can be used to collect, organise

and report data required by national health authorities should

RHD be considered a reportable disease. Examples such as the

Novartis Institutes for BioMedical Research, Cambridge,

Massachusetts, USA

Joris van Dam, PhD,

joris.vandam@novartis.com

Brigitta Tadmor, PhD

Jonathan Spector, MD, MPH

Department of Paediatrics & Child Health, University

Teaching Hospital, Lusaka, Zambia

John Musuku, BSc HB, MBcHB, MMed

Western Cape Paediatric Cardiac Services, Red Cross War

Memorial Children’s Hospital, University of Cape Town,

Cape Town, South Africa

Liesl J Zühlke, MB ChB, DCH, FCPaeds (SA), Cert Cardiology

(Paeds), MPH, FESC

Department of Medicine, Groote Schuur Hospital and

University of Cape Town, Cape Town, South Africa

Liesl J Zühlke, MB ChB, DCH, FCPaeds (SA), Cert Cardiology

(Paeds), MPH, FESC

Mark E Engel, BSc (Med) Hons, MPH, PhD

Bongani M Mayosi, BMedSci, MB ChB, DPhil, FCP (SA), FESC

Dimagi Inc, South Africa

Nick Nestle, BSEE